April 26, 2024
Market Now
Samsung BioLogics’ biosimilar granted USFDA approval
[DISCLOSURE] Samsung BioLogics (207940) announced on April 24 that its subsidiary Samsung Bioepis’ biosimilar SB2 has been granted final approval from the US Food and Drug Administration for sales in the US.
By Hwang You-mee (theinvestor@heraldcorp.com)
By Hwang You-mee (theinvestor@heraldcorp.com)
![[KH Explains] Korean shipbuilding stocks rally: Real growth or bubble?](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/25/20240425050656_0.jpg)
![[Hello India] Hyundai Motor vows to boost 'clean mobility' in India](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=151&simg=/content/image/2024/04/25/20240425050672_0.jpg)
